Aquestive Therapeutics Inc at JMP Securities Life Sciences Conference Transcript
Good morning. Thanks, everybody, for joining us again at the JMP Securities Life Science Conference. Really appreciate everybody being here in-person with us today. Starting off the morning with Aquestive Therapeutics. Excited to have Dan Barber, the company's CEO; and Ernie Toth, CFO. So welcome, Dan and Ernie.
Maybe just -- obviously, you put out some exciting data for your epinephrine program yesterday. You have the epilepsy program still working through FDA, so lots to talk about. Maybe I'll just hand it over to you, Dan, to give a quick intro.
And I think, maybe, just one important point to hit on is you took over as CEO a few weeks ago now, and I'm sure it's been a fast pace, an exciting experience. But you've been at the company a long time, so just hearing your vision would be a great place to start.
Sure, and thank you, Jason. And thank you to JMP for having us here. My vision is quite simple. AQST-109 is, by far, the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |